期刊
CLINICAL INFECTIOUS DISEASES
卷 63, 期 -, 页码 S57-S59出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciw244
关键词
antibiotic development; antimicrobial resistance; trial networks
资金
- Clinical Trials Transformation Initiative
The economics of antibiotics can be improved by infectious diseases-specific clinical trial networks. While developers would still need to implement an independent phase 1 program as well as studies focused on highly resistant pathogens, standardized procedures in a network focused on usual drug resistance phenotype isolates would permit sharing of controls and would predictably generate high-quality pivotal data for product registration while creating cost and time savings in the range of 30%-40%. This would reduce economic barriers to antibiotic development and contribute to public health.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据